The Iceland-based generic pharmaceuticals company, Actavis, announced last week that it has entered into a binding letter of intent with QRxPharma to launch MoxDuo® IR in the United States. The product launch in the U.S. is expected in the third quarter of 2012. Claudio Albrecht, CEO of Actavis said, “This partnership ... Read More...
generic pharmaceuticals
Actavis, the international generic pharmaceutical company, recently donated 170 medicine pallets to aid Libya civilians in the current crisis. The pallets include cardiology, anti-infective, pain management and gastrointestinal products amongst other medicines. “I personally thank Actavis on behalf of the Libyan people for this generous offer and the Maltese government ... Read More...
The Iceland based generic pharmaceutical company, Actavis, recently announced that its third-party sales division, Medis, has delivered around 30 million tablets of Atorvastatin to its clients in Spain. This is the first generic version of the blockbuster molecule to reach the Spanish market. Atorvastatin efficiently regulates the blood cholesterol levels and ... Read More...
Previously, it was believed that generic drugs are lower in quality and that’s the reason why they are not expensive. People use to think that generic drugs could harm their health and could lead some dangerous side effects. People are afraid of opting for generic drugs for the same reason. ... Read More...
Entering the Irish market last week, Actavis plans to create up to 25 new local jobs over the next five years and to launch more than 120 generic drugs in Ireland, with the potential to save millions of euro off the country’s annual health bill. The new roles Actavis will create ... Read More...
New analytical and R&D laboratories to expand the research and development efforts for controlled release and other technically difficult generic pharmaceutical products opened in Actavis South Atlantic, a United States division of the international generic pharmaceutical company Actavis. The labs have been expanded by about 300 sq meters and the new ... Read More...
Actavis in France was formally launched on 23rd October at a one-day conference held at the Centre Étoile-Saint Honoré, close to the Champs Elysées in Paris. Actavis started preparing its greenfield operation in France in 2007, to market and sell Actavis products on the French market. The Group’s offices in the ... Read More...
Generic pharmaceutical company Actavis has said that its operations will not be impacted by the current financial turmoil in Iceland. Actavis has released a statement in light of recent market events in the Icelandic financial sector. ”Actavis is not exposed to the Icelandic banks in regards to funding or normal banking facilities. ... Read More...
Generic drugs company Actavis has received approval from the FDA to market Bupropion Hydrochloride extended-release tablets (XL) 300mg in the US. Actavis, a leading generic drugs company based in Iceland, has received approval from the US Food & Drug Administration to market the generic drug equivalent of Wellbutrin XL. Actavis will begin ... Read More...
Following Robert Wessman’s departure as CEO, a number of changes in senior management have taken place at the generic pharmaceuticals manufacturer. Actavis Group, the international generic drug company, has announced that it has appointed Gudbjorg Edda Eggertsdottir as Deputy CEO. Valur Ragnarsson will become the new Executive Vice President of Third-Party Sales ... Read More...
The Iceland-based generic drugs manufacturer Actavis announces the opening of a new disabled access ramp to a major Bulgarian cathedral. Actavis has financed the construction of an access ramp for disabled people to a large cathedral in Bulgaria. The ramp was officially opened by Nikolay Hadjidonchev, Actavis’ Bulgaria Managing director, in ... Read More...